United States: What Employers Need To Know About Illinois' New Medical Marijuana Law

Andrew Fiske and Jennifer Froehlich are Associates in the Chicago office

On August 2, 2013, Illinois Governor Pat Quinn signed the Compassionate Use of Medical Cannabis Pilot Program Act, P.A., 98-0122. As of January 1, 2014, the Act will establish a four-year pilot program in Illinois that authorizes the cultivation and distribution of medical cannabis for the use of registered qualifying patients (RQPs). RQPs are only those patients who have certain specified debilitating medical conditions1 and obtain state registration cards.

Time to Review Manuals and Testing Policies

In addition to numerous regulations concerning the establishment and operation of cannabis cultivation centers and distribution facilities, and the requirements for dispensing and receipt of cannabis prescriptions, the Act includes specific provisions concerning the impact of the pilot program on employers of RQPs and caregivers.

Many details of the pilot program — including the adoption of related administrative rules and regulations — are not yet available; the actual prescription of medical marijuana may not begin until the middle of 2014; and specific effects of the Act on employment policies and employer liability are still unclear. Nevertheless, employers may wish to review their employee manuals and drug testing policies to anticipate whether any revisions will be appropriate in light of the Act and its related regulations.

Workplace Drug Policies and Employment Manual Provisions

Without regard to the Act, Illinois employers may prohibit illegal drug and alcohol use by employees at the workplace and require that employees not be under the influence of illegal drugs or intoxicated while at work. Employers often codify these prohibitions with a drug-free workplace policy. Such policies may stand alone and/or be in the employee handbook. They commonly include these types of provisions:

  • The manufacture, distribution, dispensation, sale, possession or use of alcohol, illegal drugs or controlled substances while on duty or on employer property is prohibited and will subject employees to immediate discharge.
  • Employees who are impaired by or under the influence of alcohol, illegal drugs or controlled substances, or who have any of the same present in their bodily systems while on duty or on employer property, will be subject to discharge.
  • Off-the-job, illegal manufacture, distribution, dispensation, sale, possession or use of illegal drugs or controlled substances will subject employees to disciplinary action, up to and including immediate discharge.
  • The employer reserves the right to search the person, vehicle and personal property of employees for contraband (including, but not limited to alcohol, illegal drugs, controlled substances and drug paraphernalia) while on duty or on employer property. The employer also reserves the right to search all employer property (including, but not limited to, employee offices, desks and lockers) for such contraband. Employees who fail to submit to or cooperate fully in such searches will be subject to disciplinary action, up to and including immediate discharge.
  • Each employee must notify the employer of any conviction under a criminal drug statute that the employee receives for a violation occurring while on duty or on employer property within five days of such conviction.
  • Employees taking a prescribed drug or controlled substance must maintain the same in the original container identifying the drug or substance, dosage, date of prescription, name of the person for whom it was prescribed and authorizing physician. Employees also must review with their employer any work restrictions that should be observed while taking the prescribed drug or substance.
  • Employees may be required to submit to a drug and/or alcohol test as a condition of continued employment. Employees who fail to submit to the required tests and/or test positive for alcohol, illegal drugs or controlled substances will be subject to immediate discharge.

Substantive Provisions of the Act Relating to Employers

In general, the Act will not prohibit employers from adopting and following the general policies set out above. Although it includes various regulations concerning employees of cannabis cultivation centers and distribution facilities, this alert focuses on the broader impact of the Act on employers who are uninvolved with the production or distribution of cannabis.


Section 40 of the Act makes clear that employers may not penalize a person solely for his or her status as an RQP or caregiver, unless failing to do so would put the employer in violation of federal law, or unless failing to do so would cause it to lose a monetary or licensing-related benefit under federal law or rules.2 Employers are not prohibited from enforcing policies concerning drug testing, zero-tolerance for drug possession or use or drug-free workplaces if those policies are applied in a non-discriminatory manner, however.3

The Act also proscribes discrimination against the employer as to the receipt of state benefits, stating that no employer may be penalized or denied any benefit under state law for employing an RQP.4

Employers and Employer Liability

Section 50 of the Act addresses specific issues related to employment and employer liability. Generally, the language of Section 50 minimizes the potential impact that the pilot program will have on workplace policies and employer liability. Specifically, it states that the Act:

  • does not prohibit employers from adopting "reasonable regulations" concerning the consumption, storage or timekeeping requirements for RQPs related to the use of medical cannabis5
  • does not prohibit employers from enforcing policies concerning drug testing, zero-tolerance or drug free workplaces, provided such policies are applied in a non-discriminatory manner6
  • does not limit employers from disciplining an employee who is an RQP for violating a workplace drug policy7
  • does not limit employers' ability to discipline an employee who is an RQP for failing a drug test if failing to do so would put the employer in violation of federal law or cause it to lose a federal contract or funding8
  • does not create a defense for a third party who fails a drug test9
  • allows an employer to consider an RQP to be impaired when he or she manifests specific, articulable symptoms while working that decrease or lessen his or her performance of the duties or tasks of the employee's job position, provided that if the employer disciplines the RQP, it must provide a reasonable opportunity to contest the basis of the determination10
  • does not create or imply a cause of action for any person against an employer for:

    • actions based on the employer's good faith belief that a registered qualifying patient used or possessed cannabis while on the employer's premises or during the hours of employment
    • actions based on the employer's good faith belief that a registered qualifying patient was impaired while working on the employer's premises during the hours of employment
    • actions based on injury or loss to a third party if the employer neither knew nor had reasons to know that the employee was impaired11
  • does not interfere with any federal restrictions on employment including but not limited to the United States Department of Transportation regulation 49 CFR 40.151(e)

Although the Act's language strives to minimize its impact on existing workplace policies and liabilities, as discussed below, employers may wish to examine existing drug testing policies and employee manual provisions to ensure that they are not discriminating against RQPs or caregivers under the Act.

Potential Effects of the Illinois Medical Marijuana Law on Employers

Because the Act creates new law, there will not be any controlling legal precedent interpreting the Act once it takes effect. Again, the Act provides significant clarity concerning various issues related to employee conduct and employer liability. Nevertheless, several questions remain concerning the potential impacts of the Act that employers should be aware of and attuned to, including the following:

Random Drug-Testing Requirements

  • Prospective employees. The Act makes clear that a person's ability to receive prescriptions for medical cannabis does not create a "defense" for a "third party" who fails a drug test. This would seem to apply to applicants for employment rather than employees, but it is unclear whether this will be actually be the case. It will be important to monitor the adoption of regulations implementing the Act to assess whether there are other impacts on potential hires that should be taken into account.
  • Existing employees. If an employer has random drug testing for current employees, the question arises: "What do we do with a current employee who is an RQP who tests positive for cannabis?" Given that the Act prohibits employers from discriminating against an employee simply because he or she is an RQP, an employer must carefully consider whether to include cannabis in random drug testing regimes, particularly since such tests do not allow the employer to identify when specifically the cannabis was consumed — i.e., during unpermitted workplace time or during permitted non-working time.
  • Triggering Events. Employment policies typically implement drug testing requirements on either a random basis or upon reasonable suspicion of policy violations. An example of a common "trigger" for such testing is an employee that is involved in a workplace accident, which then triggers a drug test under the policy. It is not clear under the Act how an employer may or should address an employee who tests positive for cannabis in a post-accident test but claims that the cannabis consumption occurred when the employee was not at work. Cannabis may remain in an employee's system for a significant period of time, and a positive test may not isolate whether the employee was using or intoxicated on the job. It is thus not yet known whether an employer may take disciplinary action based on the results of such a test or whether such an action would be unlawful discrimination based on the individual's status as an RQP. Employers should watch for further developments and seek legal advice before taking action in such situations.

Workplace policies and requirements

  • Use of Cannabis in the Workplace. The Act does not require employers to either allow RQPs to use or be under the influence of cannabis in the workplace. It is unclear, however, whether any adjustments to sick leave policies would be appropriate to allow the use of medical cannabis outside of the workplace.
  • Right to Privacy in the Workplace. The status of an employee as an RQP may impact the employee's right to privacy in certain circumstances. Employers should not disclose an employee's status as an RQP.
  • Multi-state Employment Policies. Employment policies that cover employees in multiple states may require the inclusion of state-specific information relating to the Act's impacts on Illinois-based employees. Similar information may be required to tailor specific language for employees in other states that have their own medical cannabis regulations. Care will need to be taken to ensure that employees clearly understand the impact of their state-specific regulations.

Employment Regulations to Follow

The vagaries of the Act make interpretation and analysis for employment purposes difficult at this time. As the applicable employment regulations are released, we will provide further information and guidance on the implications of the Act to Illinois employers and employees.


1 These include cancer, glaucoma, positive status for HIV, AIDS, hepatitis C, amyotrophic lateral sclerosis, Crohn's disease, agitation of Alzheimer's disease, cachexia/wasting syndrome, muscular dystrophy, severe fibromyalgia, spinal cord disease, including but not limited to arachnoiditis, Tarlov cysts, hydromyelia, syringomyelia, rheumatoid arthritis, fibrous dysplasia, spinal cord injury, traumatic brain injury and post-concussion syndrome, multiple sclerosis, Arnold-Chiari malformation and syringomyelia, spinocerebellar ataxia (SCA), Parkinson's, Tourette's syndrome, myoclonus, dystonia, reflex sympathetic dystrophy, RSD (Complex Regional Pain Syndromes Type II), neurofibromatosis, chronic inflammatory demyelinating polyneuropathy, Sjogren's syndrome, lupus, interstitial cystitis, myasthenia gravis, hydrocephalus, nail-patella syndrome, residual limb pain or the treatment of these conditions, as well as any other debilitating medical condition or its treatment that the Illinois Department of Public Health may subsequently designate by rule.

2 Act, §40(a)(1).

3 Act, §50(b).

4 Act, §40(c).

5 Act, §50(a).

6 Act, §50(b).

7 Act, §50(c).

8 Act, §50(d).

9 Act, §50(e).

10 Act, §50(f). These articulable symptoms include symptoms of the employee's speech, physical dexterity, agility, coordination, demeanor, irrational or unusual behavior, negligence or carelessness in operating equipment or machinery, disregard for the safety of the employee or others, or involvement in an accident that results in serious damage to equipment or property, disruption of a production or manufacturing process or carelessness that results in any injury to the employee or others.

11 Act, §50(g).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.